EnteroMedics (ETRM) : The consensus on EnteroMedics (ETRM) based on 2 analyst recommendation on the company stock is 2, which is interpreted as a Buy recommendation. Zacks Investment Research has issued a rank of 2 which endorses a Buy on the stock. However, 1 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 1 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating.
Also, Roth Capital downgrades their rating on the shares of EnteroMedics (NASDAQ:ETRM). The current rating of the shares is Neutral. Earlier, the shares were rated a Buy by the brokerage firm. Equity Analysts at the Firm lowers the price target to $0.5 per share from $3 per share. The rating by the firm was issued on June 9, 2016.
EnteroMedics (NASDAQ:ETRM): The stock opened in the green at $0.129 on Thursday, but the bulls found it difficult to push the prices higher. The stock reached a high of $0.13 and a low of $0.1173 for the day. The stock did not find buyers even at the lows and closed at $0.1206 recording a loss of -7.23%. 7,841,007 shares exchanged hands during the trading day. The stock had closed at $0.13 in the previous days trading.
EnteroMedics Inc. (EnteroMedics) is a medical device company. The Company is focused on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders. The Companys neuroblocking technology, which is referred to as VBLOC therapy, is designed to intermittently block the vagus nerve using high frequency, low energy, electrical impulses. The Companys initial product is the Maestro System, which uses VBLOC therapy to affect metabolic regulatory control, limits the expansion of the stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The Company has approvals to commercially launch its product, the Maestro Rechargeable System, in the United States, Australia, the European Economic Area and other countries.